Every biologic that reaches a patient's bloodstream — a monoclonal antibody, a vaccine, a CAR-T infusion — was grown inside a living host system at some point in its manufacturing journey. That host, whether a mammalian cell line, a bacterial culture, or a viral vector producer cell, leaves behind fragments of its own genetic material. Regulators call this residual host-cell DNA,...